Find a product for my lab

Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder
Devyser Placeholder

Devyser Placeholder

Fetal RHD screening NIPT

Fetal RHD determination using non-invasive prenatal testing is rapidly becoming routine as large national screening programs are being established. Workflows must now be robust, standardized and adapted to high throughput screening.

Contact me

Fetal RHD determination using Non-Invasive Prenatal Testing (NIPT) has long been the realm of research laboratories using home-made reagents, but is now entering routine laboratories as part of large prenatal screening programs. As a result, the demands on the testing procedures are changing to establish workflows that are robust, standardized and adapted to high-throughput screening. High sensitivity and specificity of the assay is critical, but it is also important to optimize the entire workflow including sample handling, data interpretation and results reporting.

Related articles

Whitepaper: Fetal RHD Screening in Clinical Routine - experiences and considerations

Scientific publications

Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis. M Neovius et al. BJOG. 2016 Jul;123(8):1337-46.

Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Wikman AT et al. Obstet Gynecol 2012 Aug; 120(2 Pt 1):227-34.

No items found.